- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
January is Glaucoma Awareness Month
January is National Glaucoma Awareness Month, and in observance, the four principal investigators of the Glaucoma Research Foundation (GRF) Catalyst for a Cure consortium will present a scientific overview of recent research advances.
San Francisco
-January is National Glaucoma Awareness Month, and in observance, the four principal investigators of the Glaucoma Research Foundation (GRF) Catalyst for a Cure consortium will present a scientific overview of recent research advances as part of the organization’s benefit Jan. 28 at the Palace Hotel in San Francisco. The event also will celebrate the group’s 31st anniversary.
“Early detection and treatment is the only way to prevent further vision loss” associated with the disease, said Thomas M. Brunner, GRF president and chief executive officer. “At GRF, we believe that a cure is attainable in the future, and National Glaucoma Awareness Month helps us raise awareness for potential treatments and cures available to glaucoma patients today.”
For more information about the event, contact Craig Palmer at 415/986-3162 or
.
Founded in 1978 in San Francisco, the GRF claims to be the oldest national foundation dedicated to preventing vision loss from glaucoma. The organization invests in research, education, and support with the ultimate goal of finding a cure.
